{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:41:50Z","timestamp":1787060510337,"version":"build-2736575974"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NEEMA; #5U38PS004649"],"award-info":[{"award-number":["NEEMA; #5U38PS004649"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214532","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T13:53:11Z","timestamp":1554817991000},"page":"e0214532","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Outlook for tuberculosis elimination in California: An individual-based stochastic model"],"prefix":"10.1371","volume":"14","author":[{"given":"Alex J.","family":"Goodell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya B.","family":"Shete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Vreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-5858","authenticated-orcid":true,"given":"Devon","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Porco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pennan M.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of Tuberculosis Incidence\u2014United States, 2013\u20132015","volume":"65","author":"JL Salinas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"K L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"ref3","unstructured":"Tuberculosis Control Branch, Report on Tuberculosis in California, 2015. California Department of Public Health, Richmond, CA. September 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/TBCB_Report_2015.pdf\" xlink:type=\"simple\">https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/TBCB_Report_2015.pdf<\/ext-link>"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s40471-016-0076-6","article-title":"Getting to Zero: Tuberculosis Elimination in California","volume":"3","author":"PM Barry","year":"2016","journal-title":"Curr Epidemiol Rep"},{"key":"ref5","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"DL Cohn","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S095026881100286X","article-title":"Modelling tuberculosis trends in the USA","volume":"140","author":"A Hill","year":"2012","journal-title":"Epidemiol Infect"},{"key":"ref7","unstructured":"Ruggles S, Flood S, Goeken R, Grover J, Meyer E, et al. IPUMS USA: Version 8.0 [dataset]. Minneapolis, MN: IPUMS, 2018. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.18128\/D010.V8.0\" xlink:type=\"simple\">https:\/\/doi.org\/10.18128\/D010.V8.0<\/ext-link>"},{"key":"ref8","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2012. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm<\/ext-link>"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country","volume":"282","author":"C Dye","year":"1999","journal-title":"JAMA"},{"key":"ref10","unstructured":"Yeats, Jessica. Controlling Tuberculosis Among High Risk Populations in Los Angeles: Three Essays. Santa Monica, CA: RAND Corporation, 2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.rand.org\/pubs\/rgs_dissertations\/RGSD356.html\" xlink:type=\"simple\">https:\/\/www.rand.org\/pubs\/rgs_dissertations\/RGSD356.html<\/ext-link>."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1164\/rccm.200510-1563OC","article-title":"The scope and impact of treatment of latent tuberculosis infection in the United States and Canada","volume":"173","author":"TR Sterling","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR06","key":"ref12","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","unstructured":"California Tuberculosis Contollers Association. California Department of Human Services &amp; California Tuberculosis Controllers Association Joint Guidelines: Targeted Testing and Treatment of Latent Tuberculosis Infection in Adults and Children. 2002. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ctca.org\/fileLibrary\/file_61.pdf\" xlink:type=\"simple\">https:\/\/ctca.org\/fileLibrary\/file_61.pdf<\/ext-link>"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e5080","DOI":"10.1371\/journal.pone.0005080","article-title":"Personal and societal health quality lost to tuberculosis","volume":"4","author":"TL Miller","year":"2009","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost\u2013effectiveness of interventions: alternative approaches","volume":"93","author":"E Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"The Cost-Effectiveness Of Testing And Treatment For Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model","volume":"177","author":"A Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"48","key":"ref18","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: A randomized trial","volume":"167","author":"R Belknap","year":"2017","journal-title":"Ann Intern Med"},{"key":"ref20","unstructured":"Centers for Medicare and Medicaid Services. Medicare physician fee schedule. Baltimore, MD: Department of Health and Human Services; 2014. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched\/PFS-Federal-Regulation-Notices-Items\/CMS-1612-FC.html\" xlink:type=\"simple\">https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched\/PFS-Federal-Regulation-Notices-Items\/CMS-1612-FC.html<\/ext-link>"},{"key":"ref21","unstructured":"Curry International Tuberculosis Center and California Department of Public Health. Tuberculosis Drug Information Guide, 2nd Edition. 2012. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.currytbcenter.ucsf.edu\/sites\/default\/files\/tbdruginfo2nded.pdf\" xlink:type=\"simple\">http:\/\/www.currytbcenter.ucsf.edu\/sites\/default\/files\/tbdruginfo2nded.pdf<\/ext-link>"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2105\/AJPH.2004.048132","article-title":"An ecological study of tuberculosis transmission in California","volume":"96","author":"WP Myers","year":"2006","journal-title":"Am J Public Health"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"20130437","DOI":"10.1098\/rstb.2013.0437","article-title":"The ongoing challenge of latent tuberculosis","volume":"369","author":"H Esmail","year":"2014","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"ref24","unstructured":"Tuberculosis Control Branch, Report on Tuberculosis in California, 2016. California Department of Public Health, Richmond, CA. August 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/TBCB_Report_2016.pdf\" xlink:type=\"simple\">https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/TBCB_Report_2016.pdf<\/ext-link>"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.socscimed.2011.05.023","article-title":"Undocumented immigrants and their use of medical services in Orange County, California","volume":"74","author":"LR Chavez","year":"2012","journal-title":"Soc Sci Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.94.7.1207","article-title":"HIV seroprevalence among homeless and marginally housed adults in San Francisco","volume":"94","author":"MJ Robertson","year":"2004","journal-title":"Am J Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1086\/594126","article-title":"Tuberculosis and illicit drug use: review and update","volume":"48","author":"RG Deiss","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/14622200500494971","article-title":"Homelessness and smoking cessation: insights from focus groups","volume":"8","author":"KS Okuyemi","year":"2006","journal-title":"Nicotine Tob Res"},{"key":"#cr-split#-ref29.1","unstructured":"9. California Department of Public Health. California Tuberculosis Risk Assessment. 2015"},{"key":"#cr-split#-ref29.2","unstructured":"10. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPHDocumentLibrary\/TBCB-CA-TB-Risk-Assessment-and-Fact-Sheet.pdf\" xlink:type=\"simple\">https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPHDocumentLibrary\/TBCB-CA-TB-Risk-Assessment-and-Fact-Sheet.pdf<\/ext-link>"},{"key":"ref30","unstructured":"Draft Recommendation Statement: Latent Tuberculosis Infection: Screening. U.S. Preventive Services Task Force. March 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementDraft\/latent-tuberculosis-infection-screening\" xlink:type=\"simple\">https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementDraft\/latent-tuberculosis-infection-screening<\/ext-link>"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/oxfordjournals.aje.a009076","article-title":"Uncertainty and sensitivity analysis of the basic reproductive rate: Tuberculosis as an example","volume":"145","author":"MA Sanchez","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup","volume":"179","author":"KM Shea","year":"2014","journal-title":"Am J Epidemiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: Prevalence estimates from the National Health and Nutrition Examination Survey, 2011\u20132012","volume":"10","author":"R Miramontes","year":"2015","journal-title":"PloS. One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e36551","DOI":"10.1371\/journal.pone.0036551","article-title":"Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic","volume":"7","author":"M Shah","year":"2012","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.5588\/ijtld.11.0102","article-title":"Programmatic impact of using QuantiFERON\u00ae-TB Gold in routine contact investigation activities","volume":"15","author":"J Grinsdale","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"D Menzies","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"CR Horsburgh","year":"2010","journal-title":"CHEST J"},{"key":"ref38","unstructured":"Centers for Medicare and Medicaid Services. Physician Fee Schedule. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PFSlookup\/index.html\" xlink:type=\"simple\">https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PFSlookup\/index.html<\/ext-link>"},{"key":"ref39","unstructured":"Centers for Medicare and Medicaid Services. Clinical Laboratory Fee Schedule. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/Clinical-Laboratory-Fee-Schedule-Files.html\" xlink:type=\"simple\">https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/Clinical-Laboratory-Fee-Schedule-Files.html<\/ext-link>"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13104-017-2754-y","article-title":"A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015","volume":"10","author":"P Oh","year":"2017","journal-title":"BMC Res Notes"},{"key":"ref41","first-page":"257","article-title":"Recent developments in treatment of latent tuberculosis infection","volume":"133","author":"D Menzies","year":"2011","journal-title":"Indian J Med Res"},{"issue":"4","key":"ref42","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"key":"ref43","unstructured":"California Health Interveiw Survey. CHIS 2001, 2003, 2007, 2011, 2014 Adult Public Use File. [computer file]. Los Angeles, CA: UCLA Center for Health Policy Research; 2015."},{"key":"ref44","unstructured":"Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: Department of Health and Human Services; 2001. at &lt;<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/brfss\/\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/brfss\/<\/ext-link>&gt;."},{"key":"ref45","first-page":"657","article-title":"Prevalence of diagnosed and undiagnosed HIV infection-United States, 2008\u20132012","volume":"64","author":"HI Hall","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn\u2019s disease and ulcerative colitis in the United States","volume":"5","author":"MD Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults","volume":"135","author":"MD Kappelman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2012.03.045","article-title":"Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease","volume":"161","author":"S Karve","year":"2012","journal-title":"J Pediatr"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/acr.22055","article-title":"Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US Medicare program","volume":"65","author":"J Zhang","year":"2013","journal-title":"Arthritis Care Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/art.10897","article-title":"Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification","volume":"48","author":"EK Rasch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"M Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"#cr-split#-ref52.1","unstructured":"16. US Department of Health and Human Services. Organ procurement and transplantation network. Organ Procure Transplant Netw. 2014"},{"key":"#cr-split#-ref52.2","unstructured":"17. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/optn.transplant.hrsa.gov\/data\/\" xlink:type=\"simple\">https:\/\/optn.transplant.hrsa.gov\/data\/<\/ext-link>"},{"key":"#cr-split#-ref53.1","unstructured":"18. United States Renal Data System. Online Query System. 2015"},{"key":"#cr-split#-ref53.2","unstructured":"19. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.usrds.org\" xlink:type=\"simple\">https:\/\/www.usrds.org<\/ext-link>"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"JJ Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T15:30:13Z","timestamp":1588951813000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214532"}},"subtitle":[],"editor":[{"given":"Katalin Andrea","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214532","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]}}}